1.32
price up icon1.54%   0.02
after-market Dopo l'orario di chiusura: 1.32
loading

Phio Pharmaceuticals Corp Borsa (PHIO) Ultime notizie

pulisher
01:07 AM

Published on: 2025-11-17 12:07:19 - newser.com

01:07 AM
pulisher
08:47 AM

Phio Pharmaceuticals Announces Upcoming Podium Presentation at the Advanced Therapies USA 2025 Congress - MarketScreener

08:47 AM
pulisher
08:45 AM

Phio Pharmaceuticals (NASDAQ: PHIO) to Present INTASYL siRNA at Advanced Therapies USA - Stock Titan

08:45 AM
pulisher
Nov 16, 2025

How Phio Pharmaceuticals Corp. (44R1) stock reacts to new regulationsJuly 2025 Institutional & Fast Momentum Stock Entry Tips - newser.com

Nov 16, 2025
pulisher
Nov 16, 2025

Will Phio Pharmaceuticals Corp. (44R1) stock profit from AI boomWeekly Trade Recap & High Conviction Investment Ideas - newser.com

Nov 16, 2025
pulisher
Nov 16, 2025

How Phio Pharmaceuticals Corp. (44R1) stock reacts to fiscal policiesIndex Update & Low Volatility Stock Recommendations - newser.com

Nov 16, 2025
pulisher
Nov 15, 2025

Can Phio Pharmaceuticals Corp. hit a new high this monthBond Market & Safe Capital Growth Tips - newser.com

Nov 15, 2025
pulisher
Nov 15, 2025

Is Phio Pharmaceuticals Corp. stock attractive for retirement portfoliosWeekly Stock Report & Safe Capital Growth Trade Ideas - newser.com

Nov 15, 2025
pulisher
Nov 15, 2025

Is Phio Pharmaceuticals Corp. stock supported by strong fundamentalsPortfolio Risk Summary & Free Growth Oriented Trading Recommendations - newser.com

Nov 15, 2025
pulisher
Nov 14, 2025

Is Phio Pharmaceuticals Corp. (44R1) stock included in top ETFsJuly 2025 Spike Watch & Technical Pattern Based Buy Signals - newser.com

Nov 14, 2025
pulisher
Nov 14, 2025

Will Phio Pharmaceuticals Corp. stock outperform tech sector in 2025Market Risk Report & Verified Momentum Stock Watchlist - Fundação Cultural do Pará

Nov 14, 2025
pulisher
Nov 14, 2025

How Phio Pharmaceuticals Corp. stock performs after earningsJuly 2025 Action & Entry Point Confirmation Alerts - Fundação Cultural do Pará

Nov 14, 2025
pulisher
Nov 13, 2025

Phio Pharmaceuticals Reports Third Quarter 2025 Financial Results and Provides Business Update - Newsfile

Nov 13, 2025
pulisher
Nov 13, 2025

Can Phio Pharmaceuticals Corp. rally from current levelsJuly 2025 Trade Ideas & Daily Stock Momentum Reports - newser.com

Nov 13, 2025
pulisher
Nov 13, 2025

What drives Phio Pharmaceuticals Corp 44R1 stock priceMACD Histogram Signals & Analyze Your Portfolio Risk in Seconds - earlytimes.in

Nov 13, 2025
pulisher
Nov 13, 2025

Top chart patterns to watch in Phio Pharmaceuticals Corp.Market Performance Report & Long-Term Capital Growth Ideas - newser.com

Nov 13, 2025
pulisher
Nov 13, 2025

Best data tools to analyze Phio Pharmaceuticals Corp. stockEarnings Risk Summary & Risk Controlled Swing Trade Alerts - newser.com

Nov 13, 2025
pulisher
Nov 12, 2025

Developing predictive dashboards with Phio Pharmaceuticals Corp. data2025 Technical Overview & Low Volatility Stock Recommendations - newser.com

Nov 12, 2025
pulisher
Nov 11, 2025

Using economic indicators to assess Phio Pharmaceuticals Corp. potentialEarnings Summary Report & Accurate Entry/Exit Alerts - newser.com

Nov 11, 2025
pulisher
Nov 11, 2025

Analyzing Phio Pharmaceuticals Corp. with multi timeframe charts2025 Price Targets & Weekly High Momentum Picks - newser.com

Nov 11, 2025
pulisher
Nov 10, 2025

Its Stock Has Paid Off Big Time For Phio Pharmaceuticals Corp - setenews.com

Nov 10, 2025
pulisher
Nov 07, 2025

Phio Pharmaceuticals to Present Recent Clinical Results from Skin Cancer Trial with siRNA based INTASYL PH-762 - Newsfile

Nov 07, 2025
pulisher
Nov 07, 2025

Phio’s INTASYL PH-762 wins immunomodulatory solution of the year By Investing.com - Investing.com South Africa

Nov 07, 2025
pulisher
Nov 07, 2025

Phio’s INTASYL PH-762 wins immunomodulatory solution of the year - Investing.com

Nov 07, 2025
pulisher
Nov 07, 2025

Phio Pharmaceuticals Announces INTASYL PH-762 is Named Immunomodulatory Solution of the Year in the BioTech Breakthrough Award Program - Newsfile

Nov 07, 2025
pulisher
Nov 07, 2025

Phio Pharma (NASDAQ: PHIO) to present Phase 1b PH-762 skin cancer results at SITC - Stock Titan

Nov 07, 2025
pulisher
Nov 06, 2025

Phio Pharmaceuticals Exercises Warrants for $13.4 Million - TipRanks

Nov 06, 2025
pulisher
Nov 06, 2025

Is Phio Pharmaceuticals Corp. stock in correction or buying zoneJuly 2025 Big Picture & AI Enhanced Trading Alerts - newser.com

Nov 06, 2025
pulisher
Nov 06, 2025

How Phio Pharmaceuticals Corp. stock benefits from tech adoptionGlobal Markets & Expert Curated Trade Setup Alerts - newser.com

Nov 06, 2025
pulisher
Nov 06, 2025

How currency fluctuations impact Phio Pharmaceuticals Corp. stockWeekly Stock Summary & Risk Adjusted Buy and Sell Alerts - newser.com

Nov 06, 2025
$16.95
price down icon 5.99%
$20.56
price up icon 1.33%
$39.16
price up icon 0.00%
$30.42
price up icon 0.53%
$102.67
price down icon 0.41%
$704.31
price up icon 1.56%
Capitalizzazione:     |  Volume (24 ore):